Dosage regimens for a combination of anti-DR5 antibodies intended for use in the treatment of cancer

MA55881AUndetermined Publication Date: 2022-03-16GENMAB BV

View PDF 0 Cites 0 Cited by

Patent Information

Application Number: MA55881
Authority / Receiving Office: MA · MA
Patent Type: Applications
Current Assignee / Owner
Priority Date: 2019-05-09
Filing Date: 2020-05-11
Publication Date: 2022-03-16

Application Information

Patent Timeline

09 May 2019

Priority

11 May 2020

Application

MA55881

16 Mar 2022

Publication

MA55881A

IPC: A61K39/00; A61P35/00; A61P35/02; C07K16/28

CPC: C07K16/2878; A61K2039/507; A61P35/00; A61P35/02; C07K2317/72; A61K2039/541; A61K2039/505; A61K2039/545

Inventors: AHMADI Tahamtan; ELLEKILDE-PEDERSEN Merete

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Patent Text Reader

Need to check novelty before this filing date? Find Prior Art

No text content released.